Bio Impact Capital LLC Portfolio Holdings

Bio Impact Capital LLC

  • $669 Million
  • Q4 2024

Bio Impact Capital LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $669 Million distributed in 47 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cullinan Oncology, Inc. with a value of $93.2M, Crinetics Pharmaceuticals, Inc. with a value of $31.5M, Edgewise Therapeutics, Inc. with a value of $28.8M, Insmed Inc with a value of $26.9M, and Natera, Inc. with a value of $25.4M.

Examining the 13F form we can see an increase of $27.7M in the current position value, from $641M to 669M.

Bio Impact Capital LLC is based out at Cambridge, MA

Below you can find more details about Bio Impact Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $669 Million
Healthcare: $669 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$385M
$93.2 Million 13.93% of portfolio
7,648,268
Q3 2021 Reduced 3.36%
$1.82B
$31.5 Million 4.72% of portfolio
617,035
Q4 2024 Added 17.34%
$1.69B
$28.8 Million 4.31% of portfolio
1,079,316
Q4 2024 Added 17.68%
$10.5B
$26.9 Million 4.02% of portfolio
389,611
Q4 2024 Reduced 36.69%
$14.3B
$25.4 Million 3.8% of portfolio
160,626
Q4 2024 Reduced 9.3%
$1.64B
$24.4 Million 3.65% of portfolio
589,579
Q4 2024 Added 19.66%
$6.91B
$21.1 Million 3.16% of portfolio
236,213
Q4 2024 Added 57.28%
$3.52B
$21 Million 3.13% of portfolio
800,000
Q4 2024 New
$1.54B
$20.4 Million 3.06% of portfolio
702,981
Q4 2024 Added 2.03%
$639M
$19.8 Million 2.96% of portfolio
2,673,905
Q4 2024 Added 11.1%
$3.72B
$19.6 Million 2.93% of portfolio
434,767
Q4 2024 Added 384.61%
$918M
$18.4 Million 2.75% of portfolio
1,489,237
Q4 2024 Added 138.48%
$1.87B
$18 Million 2.69% of portfolio
416,144
Q4 2024 New
$172M
$17 Million 2.54% of portfolio
2,912,550
Q4 2024 Added 8.65%
$1.47B
$16.8 Million 2.51% of portfolio
315,230
Q4 2024 Reduced 9.69%
$2.86B
$16.5 Million 2.46% of portfolio
391,018
Q4 2024 Added 18.59%
$4.36B
$13.8 Million 2.07% of portfolio
452,739
Q4 2024 Reduced 9.3%
$3.47B
$13.7 Million 2.05% of portfolio
313,817
Q4 2024 Added 7.7%
$258M
$13.4 Million 2.01% of portfolio
1,745,943
Q1 2022 Reduced 5.35%
$259M
$13.2 Million 1.97% of portfolio
3,094,896
Q4 2024 Added 101.16%
$2.09B
$12.8 Million 1.92% of portfolio
460,617
Q4 2024 Added 17.34%
$697M
$12.8 Million 1.92% of portfolio
1,020,559
Q4 2024 Reduced 4.3%
$281M
$12.4 Million 1.86% of portfolio
8,567,896
Q4 2024 Added 51.86%
$2.37B
$12.4 Million 1.86% of portfolio
267,497
Q4 2024 Reduced 9.3%
$1.31B
$12.3 Million 1.84% of portfolio
230,000
Q4 2024 Added 34.42%
$606M
$11.5 Million 1.72% of portfolio
950,000
Q4 2024 New
$406M
$11.1 Million 1.66% of portfolio
4,164,178
Q4 2024 New
$810M
$10.9 Million 1.63% of portfolio
257,788
Q4 2024 New
$932M
$10.6 Million 1.59% of portfolio
414,035
Q4 2024 New
$408M
$9.35 Million 1.4% of portfolio
2,268,825
Q4 2024 Added 11.6%
$14.2B
$8.12 Million 1.21% of portfolio
23,000
Q4 2024 New
$427M
$7.81 Million 1.17% of portfolio
459,943
Q4 2024 Added 109.53%
$2.31B
$7.73 Million 1.16% of portfolio
197,212
Q4 2024 Added 18.95%
$322M
$7.56 Million 1.13% of portfolio
685,826
Q4 2024 Added 43.04%
$139M
$5.71 Million 0.85% of portfolio
1,611,833
Q4 2024 Reduced 10.29%
$5.36B
$4.23 Million 0.63% of portfolio
50,000
Q4 2024 New
$70.9M
$3.97 Million 0.59% of portfolio
2,160,062
Q4 2024 Reduced 23.73%
$35.7M
$3.53 Million 0.53% of portfolio
2,388,011
Q2 2021 New
$275M
$3.45 Million 0.52% of portfolio
559,547
Q4 2024 New
$110M
$3.35 Million 0.5% of portfolio
1,106,851
Q4 2024 Reduced 24.49%
$41.7M
$2.79 Million 0.42% of portfolio
4,285,365
Q4 2024 New
$83.3M
$2.75 Million 0.41% of portfolio
5,095,912
Q2 2023 New
$42.4M
$2.32 Million 0.35% of portfolio
1,391,434
Q4 2024 Reduced 42.26%
$50.7M
$1.61 Million 0.24% of portfolio
1,231,154
Q4 2024 Reduced 24.92%
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 11.11%
Cartesian Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 14.57%

Summary

  • Portfolio
  • No. of Stocks 47
  • Current Value $669 Million
  • Prior Value $641 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 11 stocks
  • Additional Purchases 21 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email